Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Adding Acu-TENS to Breathing Muscle Training in Sickle Cell Disease

Tests adding acupuncture-like electrical nerve stimulation to breathing training in adults with sickle cell disease.

Plain-language title generated from the registry record
Registry title: Pulmonary Functions in Sickle Cell Disease: Response to Acu-TENS

Key facts

Where
Dokki, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 50 years old?

Source: NCT06757829, who can take part

Where in Egypt

  • Faculty of Physical Therapy, Cairo UniversityDokki, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Cairo University
Trial code
NCT06757829
Record updated
3 January 2025
Original description
pulmonary complications are common in sickle cell disease patients. Respiratory training using inspiratory muscle trainer (IMT) is usually a good choice to improve these complications. Recently, acupuncture like transcutaneous electrical nerve stimulation (AC-tens) may also improve these complications.Read full original descriptionShow less

Pulmonary Functions in Sickle Cell Disease: Response of Adding Acu-TENS to Inspiratory Muscle Training

pulmonary complications are common in sickle cell disease patients. Respiratory training using inspiratory muscle trainer (IMT) is usually a good choice to improve these complications. Recently, acupuncture like transcutaneous electrical nerve stimulation (AC-tens) may also improve these complications.

Inclusion: sickle cell disease patients; non obese patients.

Exclusion: patients with any systemic or chest or renal or hepatic or neurological diseases; women with lactation or pregnancy; patients atacks of vasoocclusive crisis.

ClinicalTrials.gov NCT06757829